Overview of EBOV associated (Mutation)

ID Literature Title Group
1 18199658 Inhibition of IRF-3 activation by VP35 is critical for the high level of virulence of ebola virus
Mutation
2 20071589 Mutations abrogating VP35 interaction with double-stranded RNA render Ebola virus avirulent in guinea pigs
Mutation
3 23794798 In Vivo Replication and Pathogenesis of Vesicular Stomatitis Virus Recombinant M40 Containing Ebola Virus L-Domain Sequences
Mutation
4 26925318 Initiating a watch list for Ebola virus antibody escape mutations
Mutation
5 30897171 Expanding the watch list for potential Ebola virus antibody escape mutations
Mutation
6 15225645 Roles of a conserved proline in the internal fusion peptide of Ebola glycoprotein
Mutation
7 27512112 Positive Selection Drives Evolution at the Host-Filovirus Interaction Surface
Mutation
8 27009368 Conserved differences in protein sequence determine the human pathogenicity of Ebolaviruses
Mutation
9 28812539 Investigating Ebola virus pathogenicity using molecular dynamics
Mutation
10 21246633 Effect of flanking residues on the conformational sampling of the internal fusion peptide from Ebola virus
Mutation
11 28418440 An all-atom molecular dynamics study of the anti-interferon signaling of Ebola virus: interaction mechanisms of EBOV VP24 binding to Karyopherin alpha5
Mutation
12 26466951 Exploring interaction mechanisms of the inhibitor binding to the VP35 IID region of Ebola virus by all atom molecular dynamics simulation method
Mutation
13 28110448 Molecular dynamics exploration of the binding mechanism and properties of single-walled carbon nanotube to WT and mutant VP35 FBP region of Ebola virus
Mutation
14 28205249 Exploration micromechanism of VP35 IID interaction and recognition dsRNA: A molecular dynamics simulation
Mutation
15 28298161 A simulation investigation on interaction mechanism between Ebola nucleoprotein and VP35 peptide
Mutation
16 28170013 Non-active site mutations disturb the loop dynamics, dimerization, viral budding and egress of VP40 of the Ebola virus
Mutation
Contents
Description
Disease Group Note
  • The label in Group indicates that the disease is mentioned in mutation or integration research. Click the eye label to view the corresponding module information.